5th Circuit to Hear Louisiana Challenge to Federal Abortion‑Pill Policy

Questions about this coverage

How did the left and right cover 5th Circuit to Hear Louisiana Challenge to Federal Abortion‑Pill Policy?

Of the 15 outlets on this story carrying a published leaning rating, 87% are rated left, 13% are rated centre, 0% are rated right. Those percentages are shares of the rated outlets, not of every outlet that ran it. The sections above set out what each side emphasised, in its own terms.

Is 5th Circuit to Hear Louisiana Challenge to Federal Abortion‑Pill Policy left or right?

The story itself is neither. What can be counted is who has covered it, and 87% of the 15 rated outlets on it are rated left — so far this is a story carried mostly by the left. Coverage is still arriving and that can change, which is why the figure is dated rather than fixed.

Is the coverage of 5th Circuit to Hear Louisiana Challenge to Federal Abortion‑Pill Policy biased?

5th Circuit to Hear Louisiana Challenge to Federal Abortion‑Pill Policy is one event reported by 15 outlets, and this page does not rate the story as biased or unbiased. What it publishes is the spread: which outlets ran it, where named rating organisations place each of them on the spectrum, and what each side chose to lead with. A leaning rating describes an outlet's record over time, not this article, and the two should not be run together.

Which side is not reporting 5th Circuit to Hear Louisiana Challenge to Federal Abortion‑Pill Policy?

When we first saw this story, outlets rated right had barely covered it. Coverage accretes for hours after an event, so that is where to look rather than a verdict — the split above is the current count, and it is the one to read.

Which outlets covered 5th Circuit to Hear Louisiana Challenge to Federal Abortion‑Pill Policy?

15 that we know of, every one of them listed further up this page with a link to its own report and to what we hold on the publisher. Nothing here is a summary of somebody else's summary: the outlets are named so the original reporting can be read.

What case will the 5th Circuit hear?

The 5th Circuit will hear Louisiana et al. v. Food and Drug Administration, a lawsuit that challenges the federal policy allowing mifepristone to be prescribed via telehealth without an in‑person visit. The hearing is set for Wednesday before a three‑judge panel in New Orleans.

What policy is Louisiana trying to change?

Louisiana seeks to overturn the Biden‑era rule that permits abortion pills, specifically mifepristone, to be prescribed without an in‑person medical visit. The state argues that the policy should be tightened, effectively ending remote telehealth prescriptions for the medication.

When will the arguments be heard?

The arguments will be heard on Wednesday, with a three‑judge panel of the 5th U.S. Circuit Court of Appeals convening in New Orleans to consider Louisiana’s challenge to the federal abortion‑pill policy.

How common is medication abortion now?

Medication abortion has become the most common form of abortion in the United States since the Supreme Court’s 2022 decision overturning Roe v. Wade. Throughout that period, prescriptions for abortion pills delivered through telehealth have continued to rise.